{
    "id": 32162,
    "fullName": "STK11 E317*",
    "impact": "nonsense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "STK11 E317* results in a premature truncation of the Stk11 protein at amino acid 317 of 433 (UniProt.org). E317* has been identified in the scientific literature (PMID: 31658955), but has not been biochemically characterized and therefore, its effect on Stk11 protein function is unknown (PubMed, Jan 2020).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 16927,
                    "pubMedId": 31658955,
                    "title": "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31658955"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6794,
        "geneSymbol": "STK11",
        "terms": [
            "STK11",
            "hLKB1",
            "LKB1",
            "PJS"
        ]
    },
    "variant": "E317*",
    "createDate": "01/21/2020",
    "updateDate": "01/21/2020",
    "referenceTranscriptCoordinates": {
        "id": 186780,
        "transcript": "NM_000455",
        "gDna": "chr19:g.1223013G>T",
        "cDna": "c.949G>T",
        "protein": "p.E317*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19911,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MRTX849 and Buparlisib (BKM120) synergistically inhibited growth of a lung cancer cell line harboring KRAS G12C and STK11 E317* in culture (PMID: 31658955).",
            "molecularProfile": {
                "id": 34658,
                "profileName": "KRAS G12C STK11 E317*"
            },
            "therapy": {
                "id": 9251,
                "therapyName": "Buparlisib + MRTX849",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16927,
                    "pubMedId": 31658955,
                    "title": "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31658955"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19334,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MRTX849 and Afinitor (everolimus) synergistically inhibited viability of a lung cancer cell line harboring KRAS G12C and STK11 E317* in culture, and induced tumor regression in a cell line xenograft model (PMID: 31658955).",
            "molecularProfile": {
                "id": 34658,
                "profileName": "KRAS G12C STK11 E317*"
            },
            "therapy": {
                "id": 9000,
                "therapyName": "Everolimus + MRTX849",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16927,
                    "pubMedId": 31658955,
                    "title": "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31658955"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19909,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MRTX849 and Pictilisib (GDC-0941) synergistically inhibited growth of a lung cancer cell line harboring KRAS G12C and STK11 E317* in culture (PMID: 31658955).",
            "molecularProfile": {
                "id": 34658,
                "profileName": "KRAS G12C STK11 E317*"
            },
            "therapy": {
                "id": 9252,
                "therapyName": "MRTX849 + Pictilisib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16927,
                    "pubMedId": 31658955,
                    "title": "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31658955"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34657,
            "profileName": "STK11 E317*",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34658,
            "profileName": "KRAS G12C STK11 E317*",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186781,
            "transcript": "XM_011528209",
            "gDna": "chr19:g.1226521G>T",
            "cDna": "c.949G>T",
            "protein": "p.E317*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 186783,
            "transcript": "XM_005259618",
            "gDna": "chr19:g.1223013G>T",
            "cDna": "c.949G>T",
            "protein": "p.E317*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 186780,
            "transcript": "NM_000455",
            "gDna": "chr19:g.1223013G>T",
            "cDna": "c.949G>T",
            "protein": "p.E317*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 186782,
            "transcript": "XM_005259617",
            "gDna": "chr19:g.1223013G>T",
            "cDna": "c.949G>T",
            "protein": "p.E317*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}